IDEXX Laboratories ( NASDAQ:IDXX – Get Rating ) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided EPS guidance of $9.33-$9.75 for the period, compared to the consensus EPS estimate of $9.63. The company issued revenue guidance of $3.619-$3.70 billion, compared to the consensus revenue estimate of $3.66 billion. Analysts Set New Price Targets Several research analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of IDEXX Laboratories from $525.

https://www.dailypolitical.com/2023/05/04/idexx-laboratories-nasdaqidxx-updates-fy23-earnings-guidance.html

#dailypolitical